After KuA treatment, apoptotic cells were increased dose-dependently; furthermore, the motility of KuA treated GBM cells (U251 and WJ1) were decreased significantly; In vivo experiment, KuA slowed down the tumor growth initiated from GBM cells (WJ1) and reduced the mean tumor weight significantly. This evidence concerns the gene PEDS1 and glioblastoma.